MOTS (Motus GI Holdings) Other Current Liabilities: $0.07 Mil (As of Mar. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MOTS Motus GI Holdings Inc MOTS
12 GF Score
Price $0.00
View Full Analysis

What is Motus GI Holdings Other Current Liabilities?

Motus GI Holdings MOTS -99.00% 12 Other Current Liabilities is $0.07 Mil as of Mar. 2024. GuruFocus rates MOTS with a GF Score™ of 12/100.

Motus GI Holdings's other current liabilities for the quarter that ended in Mar. 2024 was $0.07 Mil.

Motus GI Holdings's quarterly other current liabilities increased from Sep. 2023 ($0.06 Mil) to Dec. 2023 ($0.23 Mil) but then declined from Dec. 2023 ($0.23 Mil) to Mar. 2024 ($0.07 Mil).

Motus GI Holdings's annual other current liabilities increased from Dec. 2021 ($0.01 Mil) to Dec. 2022 ($0.05 Mil) and increased from Dec. 2022 ($0.05 Mil) to Dec. 2023 ($0.23 Mil).

Motus GI Holdings Other Current Liabilities Related Terms

Motus GI Holdings Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Motus GI Holdings's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Motus GI Holdings Other Current Liabilities Chart

Motus GI Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only 0.27 0.06 0.01 0.05 0.23

Motus GI Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.04 0.06 0.23 0.07
MOTS
12GF Score
Motus GI Holdings Inc MOTS
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Motus GI Holdings Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.07 Mil mean?
Motus GI Holdings (MOTS) has a Other Current Liabilities of $0.07 Mil as of Mar. 2024. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Motus GI Holdings.
Is Motus GI Holdings' Other Current Liabilities too high?
Motus GI Holdings' current Other Current Liabilities is $0.07 Mil. Overall, Motus GI Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Motus GI Holdings' Other Current Liabilities compare to ABT and BSX?
Motus GI Holdings' Other Current Liabilities of $0.07 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Motus GI Holdings. Motus GI Holdings's current Other Current Liabilities is $0.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Motus GI Holdings stock overvalued right now?
Motus GI Holdings (MOTS) has a current Other Current Liabilities of $0.07 Mil. The current Other Current Liabilities is $0.07 Mil. Motus GI Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Motus GI Holdings (MOTS), the current Other Current Liabilities is $0.07 Mil as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Motus GI Holdings Business Description

Address 1301 East Broward Boulevard, 3rd Floor, Fort Lauderdale, FL, USA, 33301
Motus GI Holdings Inc is a medical technology company dedicated to improving endoscopy outcomes, lowering costs, and enhancing patient experiences. The company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the FDA) to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System is also CE marked in the European Economic Area (EEA) for use in colonoscopy.
12GF Score

Get the complete analysis for MOTS

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price